Global Follicular Thyroid Cancer Drug Industry Research Report 2020, Forecast to 2025

August 2020 | 102 pages | ID: G96F29D1368DEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Follicular Thyroid Cancer Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Follicular Thyroid Cancer Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Follicular Thyroid Cancer Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Follicular Thyroid Cancer Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Follicular Thyroid Cancer Drug market are discussed.

The market is segmented by types:

• Cabozantinib S-Malate
• Dabrafenib Mesylate
• Everolimus
• Sunitinib Malate
• Others

It can be also divided by applications:

• Hospital
• Clinic
• Others

And this report covers the historical situation, present status and the future prospects of the global Follicular Thyroid Cancer Drug market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• AstraZeneca PLC
• Novartis AG
• Exelixis, Inc.
• GlaxoSmithKline plc
• Pfizer Inc.

Report Includes:

• xx data tables and xx additional tables
• An overview of global Follicular Thyroid Cancer Drug market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Follicular Thyroid Cancer Drug market
• Profiles of major players in the industry, including AstraZeneca PLC, Novartis AG, Exelixis, Inc., GlaxoSmithKline plc, Pfizer Inc......

Research Objectives

• To study and analyze the global Follicular Thyroid Cancer Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Follicular Thyroid Cancer Drug market by identifying its various subsegments.
• Focuses on the key global Follicular Thyroid Cancer Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Follicular Thyroid Cancer Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Follicular Thyroid Cancer Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Follicular Thyroid Cancer Drug Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Follicular Thyroid Cancer Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 FOLLICULAR THYROID CANCER DRUG INDUSTRY OVERVIEW

2.1 Global Follicular Thyroid Cancer Drug Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Follicular Thyroid Cancer Drug Global Import Market Analysis
  2.1.2 Follicular Thyroid Cancer Drug Global Export Market Analysis
  2.1.3 Follicular Thyroid Cancer Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Cabozantinib S-Malate
  2.2.2 Dabrafenib Mesylate
  2.2.3 Everolimus
  2.2.4 Sunitinib Malate
  2.2.5 Others
2.3 Market Analysis by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
2.4 Global Follicular Thyroid Cancer Drug Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Follicular Thyroid Cancer Drug Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Follicular Thyroid Cancer Drug Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Follicular Thyroid Cancer Drug Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Follicular Thyroid Cancer Drug Manufacturer Market Share
  2.4.5 Top 10 Follicular Thyroid Cancer Drug Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Follicular Thyroid Cancer Drug Market
  2.4.7 Key Manufacturers Follicular Thyroid Cancer Drug Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Follicular Thyroid Cancer Drug Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Follicular Thyroid Cancer Drug Industry Impact
  2.7.1 How the Covid-19 is Affecting the Follicular Thyroid Cancer Drug Industry
  2.7.2 Follicular Thyroid Cancer Drug Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Follicular Thyroid Cancer Drug Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Follicular Thyroid Cancer Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL FOLLICULAR THYROID CANCER DRUG MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Follicular Thyroid Cancer Drug Sales Market Share by Region
4.2 Global Follicular Thyroid Cancer Drug Revenue Market Share by Region (2015-2019)
4.3 Global Follicular Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Follicular Thyroid Cancer Drug Market Size Detail
  4.4.1 North America Follicular Thyroid Cancer Drug Sales Growth Rate (2015-2020)
  4.4.2 North America Follicular Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Follicular Thyroid Cancer Drug Market Size Detail
  4.5.1 Europe Follicular Thyroid Cancer Drug Sales Growth Rate (2015-2020)
  4.5.2 Europe Follicular Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Follicular Thyroid Cancer Drug Market Size Detail
  4.6.1 Japan Follicular Thyroid Cancer Drug Sales Growth Rate (2015-2020)
  4.6.2 Japan Follicular Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Follicular Thyroid Cancer Drug Market Size Detail
  4.7.1 China Follicular Thyroid Cancer Drug Sales Growth Rate (2015-2020)
  4.7.2 China Follicular Thyroid Cancer Drug Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL FOLLICULAR THYROID CANCER DRUG MARKET SEGMENT BY TYPE

5.1 Global Follicular Thyroid Cancer Drug Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Follicular Thyroid Cancer Drug Sales and Market Share by Type (2015-2020)
  5.1.2 Global Follicular Thyroid Cancer Drug Revenue and Market Share by Type (2015-2020)
5.2 Cabozantinib S-Malate Sales Growth Rate and Price
  5.2.1 Global Cabozantinib S-Malate Sales Growth Rate (2015-2020)
  5.2.2 Global Cabozantinib S-Malate Price (2015-2020)
5.3 Dabrafenib Mesylate Sales Growth Rate and Price
  5.3.1 Global Dabrafenib Mesylate Sales Growth Rate (2015-2020)
  5.3.2 Global Dabrafenib Mesylate Price (2015-2020)
5.4 Everolimus Sales Growth Rate and Price
  5.4.1 Global Everolimus Sales Growth Rate (2015-2020)
  5.4.2 Global Everolimus Price (2015-2020)
5.5 Sunitinib Malate Sales Growth Rate and Price
  5.5.1 Global Sunitinib Malate Sales Growth Rate (2015-2020)
  5.5.2 Global Sunitinib Malate Price (2015-2020)
5.6 Others Sales Growth Rate and Price
  5.6.1 Global Others Sales Growth Rate (2015-2020)
  5.6.2 Global Others Price (2015-2020)

6 GLOBAL FOLLICULAR THYROID CANCER DRUG MARKET SEGMENT BY APPLICATION

6.1 Global Follicular Thyroid Cancer DrugSales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)

7 GLOBAL FOLLICULAR THYROID CANCER DRUG MARKET FORECAST

7.1 Global Follicular Thyroid Cancer Drug Sales, Revenue Forecast
  7.1.1 Global Follicular Thyroid Cancer Drug Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Follicular Thyroid Cancer Drug Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Follicular Thyroid Cancer Drug Price and Trend Forecast (2020-2025)
7.2 Global Follicular Thyroid Cancer Drug Sales Forecast by Region (2020-2025)
  7.2.1 North America Follicular Thyroid Cancer Drug Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Follicular Thyroid Cancer Drug Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Follicular Thyroid Cancer Drug Production, Revenue Forecast (2020-2025)
  7.2.4 China Follicular Thyroid Cancer Drug Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF FOLLICULAR THYROID CANCER DRUG INDUSTRY KEY MANUFACTURERS

8.1 AstraZeneca PLC
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 AstraZeneca PLC Follicular Thyroid Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 AstraZeneca PLC News
8.2 Novartis AG
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Novartis AG Follicular Thyroid Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Novartis AG News
8.3 Exelixis, Inc.
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Exelixis, Inc. Follicular Thyroid Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Exelixis, Inc. News
8.4 GlaxoSmithKline plc
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 GlaxoSmithKline plc News
8.5 Pfizer Inc.
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Pfizer Inc. Follicular Thyroid Cancer Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Pfizer Inc. News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Follicular Thyroid Cancer Drug Picture
Figure Research Programs/Design for This Report
Figure Global Follicular Thyroid Cancer Drug Market by Regions (2019)
Table Global Market Follicular Thyroid Cancer Drug Comparison by Regions (M USD) 2019-2025
Table Global Follicular Thyroid Cancer Drug Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Follicular Thyroid Cancer Drug by Type in 2019
Figure Cabozantinib S-Malate Picture
Figure Dabrafenib Mesylate Picture
Figure Everolimus Picture
Figure Sunitinib Malate Picture
Figure Others Picture
Table Global Follicular Thyroid Cancer Drug Sales by Application (2019-2025)
Figure Global Follicular Thyroid Cancer Drug Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Follicular Thyroid Cancer Drug Sales by Manufacturer (2018-2020)
Figure Global Follicular Thyroid Cancer Drug Sales Market Share by Manufacturer in 2019
Table Global Follicular Thyroid Cancer Drug Revenue by Manufacturer (2018-2020)
Figure Global Follicular Thyroid Cancer Drug Revenue Market Share by Manufacturer in 2019
Table Global Follicular Thyroid Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Follicular Thyroid Cancer Drug Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Follicular Thyroid Cancer Drug Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Follicular Thyroid Cancer Drug Market
Table Key Manufacturers Follicular Thyroid Cancer Drug Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Follicular Thyroid Cancer Drug
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Follicular Thyroid Cancer Drug Sales (K Units) by Region (2015-2020)
Table Global Follicular Thyroid Cancer Drug Sales Market Share by Region (2015-2019)
Figure Global Follicular Thyroid Cancer Drug Sales Market Share by Region (2015-2019)
Figure Global Follicular Thyroid Cancer Drug Sales Market Share by Region in 2018
Table Global Follicular Thyroid Cancer Drug Revenue (Million US$) by Region (2015-2020)
Table Global Follicular Thyroid Cancer Drug Revenue Market Share by Region (2015-2020)
Figure Global Follicular Thyroid Cancer Drug Revenue Market Share by Region (2015-2020)
Figure Global Follicular Thyroid Cancer Drug Revenue Market Share by Region in 2019
Table Global Follicular Thyroid Cancer Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Follicular Thyroid Cancer Drug Sales (K Units) Growth Rate (2015-2020)
Table North America Follicular Thyroid Cancer Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Follicular Thyroid Cancer Drug Sales (K Units) Growth Rate (2015-2020)
Table Europe Follicular Thyroid Cancer Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Follicular Thyroid Cancer Drug Sales (K Units) Growth Rate (2015-2020)
Table Japan Follicular Thyroid Cancer Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Follicular Thyroid Cancer Drug Sales (K Units) Growth Rate (2015-2020)
Table China Follicular Thyroid Cancer Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Follicular Thyroid Cancer Drug Sales by Type (2015-2020)
Table Global Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
Figure Global Follicular Thyroid Cancer Drug Sales Market Share by Type in 2019
Table Global Follicular Thyroid Cancer Drug Revenue by Type (2015-2020)
Table Global Follicular Thyroid Cancer Drug Revenue Market Share by Type (2015-2020)
Figure Global Follicular Thyroid Cancer Drug Revenue Market Share by Type in 2019
Figure Global Cabozantinib S-Malate Sales Growth Rate (2015-2020)
Figure Global Cabozantinib S-Malate Price (2015-2020)
Figure Global Dabrafenib Mesylate Sales Growth Rate (2015-2020)
Figure Global Dabrafenib Mesylate Price (2015-2020)
Figure Global Everolimus Sales Growth Rate (2015-2020)
Figure Global Everolimus Price (2015-2020)
Figure Global Sunitinib Malate Sales Growth Rate (2015-2020)
Figure Global Sunitinib Malate Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Follicular Thyroid Cancer Drug Sales by Application (2015-2020)
Table Global Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)
Figure Global Follicular Thyroid Cancer Drug Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Follicular Thyroid Cancer Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Follicular Thyroid Cancer Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Follicular Thyroid Cancer Drug Price and Trend Forecast (2020-2025)
Table Global Follicular Thyroid Cancer Drug Sales (K Units) Forecast by Region (2020-2025)
Figure Global Follicular Thyroid Cancer Drug Production Market Share Forecast by Region (2020-2025)
Figure North America Follicular Thyroid Cancer Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Follicular Thyroid Cancer Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Follicular Thyroid Cancer Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Follicular Thyroid Cancer Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Follicular Thyroid Cancer Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Follicular Thyroid Cancer Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Follicular Thyroid Cancer Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Follicular Thyroid Cancer Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table AstraZeneca PLC Company Profile
Figure Follicular Thyroid Cancer Drug Product Picture and Specifications of AstraZeneca PLC
Table Follicular Thyroid Cancer Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca PLC Follicular Thyroid Cancer Drug Market Share (2018-2020)
Table AstraZeneca PLC Main Business
Table AstraZeneca PLC Recent Development
Table Novartis AG Company Profile
Figure Follicular Thyroid Cancer Drug Product Picture and Specifications of Novartis AG
Table Follicular Thyroid Cancer Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis AG Follicular Thyroid Cancer Drug Market Share (2018-2020)
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Exelixis, Inc. Company Profile
Figure Follicular Thyroid Cancer Drug Product Picture and Specifications of Exelixis, Inc.
Table Follicular Thyroid Cancer Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Exelixis, Inc. Follicular Thyroid Cancer Drug Market Share (2018-2020)
Table Exelixis, Inc. Main Business
Table Exelixis, Inc. Recent Development
Table GlaxoSmithKline plc Company Profile
Figure Follicular Thyroid Cancer Drug Product Picture and Specifications of GlaxoSmithKline plc
Table Follicular Thyroid Cancer Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure GlaxoSmithKline plc Follicular Thyroid Cancer Drug Market Share (2018-2020)
Table GlaxoSmithKline plc Main Business
Table GlaxoSmithKline plc Recent Development
Table Pfizer Inc. Company Profile
Figure Follicular Thyroid Cancer Drug Product Picture and Specifications of Pfizer Inc.
Table Follicular Thyroid Cancer Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Inc. Follicular Thyroid Cancer Drug Market Share (2018-2020)
Table Pfizer Inc. Main Business
Table Pfizer Inc. Recent Development
Table of Appendix